New Drug Keeps Common Breast Cancer Under Control Longer: Study

Adding Ibrance to standard hormone therapy kept disease from progressing for nine months Source: HealthDay Related MedlinePlus Pages: Breast Cancer, Medicines
Source: MedlinePlus Health News - Category: Consumer Health News Source Type: news